UserName:
BALTI (Beta-Agonist Lung Injury Trial)
A multicentre randomized, double-blind, placebo-controlled trial to evaluate intravenous infusion of Salbutamol versus placebo for 28-day mortality in patients with acute respiratory distress syndrome.